How Shaver Shop became a pandemic success story
COVID-19 lockdowns left many of us attempting home hair cuts for the first time, and Shaver Shop was quick to ramp up its online presence to meet demand.
ASX-listed biotech Neuren awaiting lucrative FDA approval
Our hot stock of the week, Neuren Pharmaceuticals, could soon be one of a handful of ASX-listed companies with an FDA-approved drug.
Should you buy, hold or sell Nine Entertainment shares?
If Nine successfully makes the transition to serving people the entertainment they want in the way they want it, there is every chance it could become a hit investment.
Should you buy, hold or sell IPH Limited shares?
More than 42,000 patents were filed in Australia in the last financial year, so is now the time to invest in an IP services group like IPH Limited?
How two years of COVID-19 have affected Codan shares
We last wrote about Codan in March 2020, as Australia shuttered its borders against COVID-19. Two years on, how has the company fared?
Why this tech stock is still profitable despite falls across the sector
The technology sector has lost its allure over the past few months, but not all tech stocks are equal, as this 50-year-old company shows.
Why you should consider furnishing your portfolio with Nick Scali
Nick Scali revenue has grown at record rates as people, unable to travel, splurged on sprucing up their homes.
The wheels of good fortune may continue to turn for investors in NTD
But the performance of National Tyre and Wheel (ASX:NTD) is likely to be more tractor-like than Formula 1 in the near future.
Why boring companies often make the best investments
While headlines are touting companies with AI-fuelled this, and disruptive that, companies that just sell quality products don't get much attention.
The surprising aviation success story: How PTB soared during lockdown
While the coronavirus pandemic hit the airline industry hard, aircraft maintenance group PTB Global has had a record year of earnings.